EVOK - Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference | Benzinga
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI® (metoclopramide) nasal spray, announced that its abstract demonstrating enhanced gastroparesis care in women using nasal metoclopramide will be presented at the 2024 Digestive Disease Week Conference (DDW 2024) taking place May 18-21, 2024 in Washington D.C.
"Being patient-centric is at the core of our mission as a company. At DDW 2024, our poster presentation will highlight the additional benefits of GIMOTI with improving healthcare experiences and patient outcomes. We are particularly excited about the positive therapeutic impact on women, the demographic most affected by gastroparesis worldwide. This event will also provide us with the opportunity to further showcase the fewer physician office visits, inpatient hospitalizations, and emergency department visits for women suffering from diabetic gastroparesis by treating with Gimoti compared to oral metoclopramide," commented Matt D'Onofrio, CEO of Evoke Pharma.
Details of the poster presentation are as follows:
Abstract Title: Transforming Diabetic Gastroparesis Care in Women: Insights from Nasal Metoclopramide Usage
Presenter & Lead Author: David C. Kunkel, MD, Gastroenterologist and Associate Professor of Medicine, University of San Diego Health
Presentation Session: Gastroparesis and Small Intestinal Dysmotility
Poster#: 1663
Date & Time: Monday, May 20 from 12:30 – 1:30 p.m. ET
Abstracts will be available on the DDW ePosters site and to conference attendees in the DDW meeting planner and mobile app after 12:01 a.m. on Sunday, May 19, 2024.
Check out Evoke Pharma at DDW 2024:
For more information on GIMOTI or our poster presentation, visit Evoke at booth #737.
About Digestive Disease Week® (DDW)
Digestive Disease Week® (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA), the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW is an in-person and online meeting from May 18-21, 2024. The meeting showcases more than 4,400 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at